首页> 外文会议>World biomaterials congress >Hollow Manganese Phosphate Nanoparticles as a Bifunctional Agent for Cancer Cell Targeted Magnetic Resonance Imaging and Drug Delivery
【24h】

Hollow Manganese Phosphate Nanoparticles as a Bifunctional Agent for Cancer Cell Targeted Magnetic Resonance Imaging and Drug Delivery

机译:作为癌细胞靶向磁共振成像和药物递送的空心锰磷酸盐纳米粒子作为双官能试剂

获取原文

摘要

Hollow nanoparticles (NPs) with sizes of less than 100 nm have shown great potential in bio-imaging and drug delivery applications. However, most of as-synthetized NPs are hydrophobic. Various approaches has been reported to turn hydrophobic NPs into hydrophilic, among of which, coating silane on NPs is one of the most common ways. There has been emerging numerous of biomedical imaging technologies in recent years, and magnetic resonance imaging (MRI) is one of the most powerful and non-invasive diagnostic techniques based on the interaction of protons with the surrounding molecules. Recently, hollow Mn_3O_4 NPs were found to improve the MRI contrast effect. In addition, multifunctional agents for diagnosis and therapeutics were also rapidly developed in recent decades. However, manganese-based positive contrast agents were only limited in some manganese oxides, manganese phosphate NPs (MNPs) with high relaxivity have rarely been reported. In this work, we designed a controlled ion transfer process to prepare hollow manganese phosphate NPs as previously reported. XRD and TEM results confirmed the crystalline phase and particle size to be 15 nm with a 5 nm hollow structure. To transfer the NPs into water, PEGylation 3-aminopropyltrimethoxysilane (APS-PEG) was synthesized through DCC/NHS reaction and then then linked to MNPs. TGA and FTIR confirmed the formation of APS-PEG. To promote the binding to cancer cells, folic acid (FA) was bind to MNPs as a target molecular to form Mn_3(PO_4)_2@APS- PEG-FA NPs (MNPs-FA). TEM characterization indicated the morphology of the NPs remained and their size to be 20 nm. DLS analysis is in agreement with this size. The formed MNPs-FA were well dispersed in water and examined their relaxivity at 1.5T MR system. T_1 and T_2 relaxation (r_1 and r_2) were 4.03 mM~(-1)s~(-1) and 37.97 mM~(-1)s~(-1) respectively. Anti-cancer drug Doxorubicin (DOX) was loaded into the MNPs by mixing MNPs-FA with DOX in water to form Mn_3(PO_4)_2@APS-PEG-FA-DOX NPs (MNPs-FA-DOX) and dispersed into water in various pH. The drug release capacities of MNPs-FA-DOX at pH=5.4 and 7.4 were investigated by UV-Vis spectrometer at λ~470nm. DOX released at pH=5.4 is five times greater than that of pH=7.4, which indicated that the NPs are pH sensitive. The cytotoxicity of MNPs-FA-DOX at the DOX concentration varied from 86.2 μM to 2.7 μM was evaluated on Hela cells, compared with free DOX and MNPs-FA using an MTT assay. The results showed MNPs-FA are biocompatible even at Mn concentration of 100 μg/ml, MNPs-FA-DOX, however, showed a dose-dependent cytotoxic, which was smaller than that of equivalent amount of free DOX. To validate the targeting effect of the NPs for targeting delivery of DOX, cytotoxicity of MNPs-FA-DOX in KB cells (strong overexpress FA receptors), Hela cells (medium express FA receptors) and A549 cells (FA receptors negative) was investigated by MTT assay. Greater cytotoxicity was observed in KB cells compared with Hela cells, while for A549 cells, the least cytotoxicity it performed, which demonstrated the targeting effect of the MNPs-FA-DOX through the receptor-mediated delivery pathway. DOX in MNPs-FA-DOX NPs allowed further confocal microscopic imaging of the cellular uptake of the NPs. After incubation with KB, Hela and A549 cells for 2 h, a strong fluorescence was observed in the cytoplasm of the KB cells and mediate fluorescence in Hela cells, compared with that of A549 cells, which showed almost no fluorescence signal under similar condition. In comparison with the non-targeted MNPs-DOX, targeting NPs MNPs-FA-DOX treated KB cells were more fluorescent, indicating higher cellular uptake of the NPs. Flow cytometry assay also confirmed the results. Inductively coupled plasma atomic emission spectroscopy (ICP-AES) was used for further investigating the cellular uptake of the NPs by measure Mn concentration in each cell after incubation with NPs with various concentrations of Mn. The result showed that KB ce
机译:尺寸小于100nm的空心纳米颗粒(NPS)在生物成像和药物递送应用中显示出巨大的潜力。然而,大多数原酸NPS是疏水的。据报道,各种方法将疏水性NP转化为亲水,其中,NPS上的涂层硅烷是最常见的方式之一。近年来已经出现了许多生物医学成像技术,磁共振成像(MRI)是基于质子与周围分子的相互作用的最强大和非侵入性的诊断技术之一。最近,发现空心MN_3O_4 NPS改善MRI对比效果。此外,近几十年,诊断和治疗剂的多官能药物也迅速发展。然而,基于锰的阳性造影剂仅在一些氧化锰中限制,很少报告具有高松弛率的锰磷酸盐NPS(MNP)。在这项工作中,我们设计了一种受控离子转移过程,以制备如前所述的中空磷酸盐NPS。 XRD和TEM结果证实结晶相和粒度为15nm,具有5nm中空结构。为了将NPS转移到水中,通过DCC / NHS反应合成PEG化3-氨基丙基三甲氧基硅烷(APS-PEG),然后与MNP连接。 TGA和FTIR确认了APS-PEG的形成。为了促进与癌细胞的结合,叶酸(Fa)与MnPS结合为靶分子以形成Mn_3(PO_4)_2 _2 @ APS-PEG-FA NPS(MNPS-FA)。 TEM表征表明,NPS的形态仍然存在,其尺寸为20nm。 DLS分析与这种大小一致。形成的MNPS-Fa良好分散在水中,并在1.5T MR系统中检查它们的松弛率。 T_1和T_2弛豫(R_1和R_2)分别为4.03mm〜(-1)和37.97mm〜(-1)S〜(-1)。通过在水中将MNPS-FA与DOX混合以形成MN_3(PO_4)_2 @ APS-PEG-FA-DOX NPS(MNPS-FA-DOX)并分散到水中并分散到水中,将抗癌药物(DOX)加载到MNP中。各种ph。通过λ〜470nm的UV-Vis光谱仪研究了pH = 5.4和7.4的MNPS-FA-DOX的药物释放容量。在pH = 5.4处释放的DOX是pH = 7.4的五倍,表明NPS是pH敏感的。与使用MTT测定的游离DOX和MNPS-FA相比,在HeLa细胞上评估了在Leha细胞中不同86.2μm至2.7μm的mnps-fa-dox的细胞毒性。结果表明MNPS-FA也是生物相容性,即使在100μg/ ml的Mn浓度下,MNPS-FA-DOX显示出剂量依赖性细胞毒性,其小于等同量的自由DOX。为了验证NPS的靶向效果,用于靶向DOX的递送,在KB细胞中MNPS-FA-DOX的细胞毒性(强过度表达FA受体),HELA细胞(培养基表达FA受体)和A549细胞(FA受体负数)进行研究MTT测定。与HeLa细胞相比,在KB细胞中观察到更大的细胞毒性,而对于A549细胞,其进行的最低细胞毒性,其证明了通过受体介导的递送途径的MNPS-FA-DOX的靶向效果。在MNPS-FA-DOX中的DOX允许进一步共聚焦的NPS蜂窝摄取的显微镜成像。与KB,Hela和A549细胞孵育2小时后,在KB细胞的细胞质中观察到强荧光,并与A549细胞的荧光介导,与A549细胞相比,在类似条件下显示几乎没有荧光信号。与非靶向MNPS-DOX相比,靶向NPS MNPS-FA-DOX处理的KB细胞更荧光,表明NPS的较高细胞吸收。流式细胞术测定还证实了结果。电感耦合等离子体原子发射光谱(ICP-AES)用于进一步研究在用各种浓度Mn的NPS孵育后测量每个细胞中的Mn浓度的NPS的细胞吸收。结果表明KB CE

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号